Ontario Teachers' Pension Plan Board’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-10,092
Closed -$1.27M – 290
2025
Q2
$1.27M Sell
10,092
-5,287
-34% -$606K 0.03% 192
2025
Q1
$1.7M Buy
+15,379
New +$1.95M 0.03% 182
2024
Q3
– Sell
-31,439
Closed -$4.33M – 468
2024
Q2
$4.33M Buy
31,439
+2,627
+9% +$360K 0.04% 88
2024
Q1
$3.97M Buy
28,812
+12,149
+73% +$1.66M 0.03% 111
2023
Q4
$2.2M Sell
16,663
-3,438
-17% -$396K 0.02% 201
2023
Q3
$2.26M Buy
+20,101
New +$2.12M 0.02% 197
2022
Q2
– Sell
-4,786
Closed -$449K – 508
2022
Q1
$449K Buy
+4,786
New +$406K 0.01% 361

Other funds holding NBIX

Ontario Teachers' Pension Plan Board's NBIX Position: Q3 2025 in Review

Ontario Teachers' Pension Plan Board sold out of Neurocrine Biosciences (NBIX) in Q3 2025, closing a stake of 10,092 shares — an estimated $1.27M sold.

Ontario Teachers' Pension Plan Board first reported a position in NBIX in Q1 2022 and held it in 7 quarters. The position peaked at $4.33M in Q2 2024. 650 funds tracked by Wall St. Rank hold NBIX as of Q3 2025.

  • Ontario Teachers' Pension Plan Board reported no remaining Neurocrine Biosciences position as of Q3 2025 after selling out during the quarter.
  • Ontario Teachers' Pension Plan Board sold 10,092 Neurocrine Biosciences shares in Q3 2025, an estimated $1.27M.
  • Ontario Teachers' Pension Plan Board first reported a position in Neurocrine Biosciences in Q1 2022 and held it in 7 quarters.
  • Ontario Teachers' Pension Plan Board's Neurocrine Biosciences position peaked at $4.33M in Q2 2024.
  • 650 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2025.

Based on Ontario Teachers' Pension Plan Board's 13F filing for Q3 2025, filed 7 Nov 2025.